Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hungund, B. L.
Right arrow Articles by Basavarajappa, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hungund, B. L.
Right arrow Articles by Basavarajappa, B. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Alcohol and Alcoholism Vol. 35, No. 2, pp. 126-133, 2000
© 2000 Medical Council on Alcoholism


Review

ARE ANANDAMIDE AND CANNABINOID RECEPTORS INVOLVED IN ETHANOL TOLERANCE? A REVIEW OF THE EVIDENCE

B. L. Hungund1,2,* and B. S. Basavarajappa1

1 Division of Analytical Psychopharmacology, New York State Psychiatric Institute and
2 Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 100032, USA

Received 9 June 1999; first review notified 23 August 1999; accepted 7 October 1999

ABSTRACT

There have been significant developments towards the elucidation of molecular and cellular changes in neuronal second messenger pathways involved in the development of tolerance to and dependence on ethanol (EtOH). The long-term exposure to EtOH has been shown to affect several aspects of neuronal signal transduction as well as ligand-gated ion channels and receptor systems, including the receptors that are coupled to the superfamily of GTP binding regulatory proteins (G-proteins). The recent identification of a G-protein coupled receptor that was activated by {delta}-9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, led to the discovery of endogenous agonists. One such agonist found to exist in mammalian brain was characterized to be an arachidonic acid (AA) metabolite and was named anandamide (AnNH). AnNH has been shown to bind specifically to the cannabinoid receptor (CB1) and mimic many of the pharmacological and behavioural effects of THC including tolerance development. The role of endocannabinoids and the CB1 receptor signal transduction system in tolerance development to drugs of abuse has not been explored until recently. The findings presented in this review provide evidence for the first time that some of the pharmacological actions of EtOH including tolerance development may be mediated through participation of the endocannabinoid–CB1 receptor signal transduction system. Recent studies have shown that chronic EtOH exposure produces downregulation of CB1 receptors and an inhibition of CB1 receptor agonist-stimulated GTP{gamma}S binding in mouse brain synaptic plasma membranes (SPM). The observed receptor downregulation results from the persistent stimulation of the receptors by the endogenous CB1 receptor agonist AnNH, the synthesis of which is increased by chronic EtOH exposure. Further, the CB1 receptor antagonist SR-141716A has been shown to block voluntary EtOH intake in rats and mice. Based on these studies, a hypothesis is presented to explain the possible involvement of the endocannabinoid system in the pharmacological and behavioural effects of EtOH.

Abbreviations: AA, arachidonic acid • AAPC, arachidonyl-PC • AnNH, anandamide • CB1, cannabinoid receptors • DA, dopamine • EtOH, ethanol • FAEE, fatty acid ethyl esters • LTP, long-term potentiation • NAE, N-acyl ethanolamide • NAPE, N-acyl ethanolamine • N-ArPE, N-arachidonylphosphatidylethanolamine • PC, phosphatidylcholine • PL, phospholipid • PLA2, phospholipase A2 • PLD, phospholipase D • PMSF, phenylmethylsulphonyl fluoride • PTX, pertussis toxin • SPM, synaptic plasma membranes • THC, tetrahydrocannabinol.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Alcohol AlcoholHome page
F. RODRIGUEZ de FONSECA, I. DEL ARCO, F. J. BERMUDEZ-SILVA, A. BILBAO, A. CIPPITELLI, and M. NAVARRO
THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGY
Alcohol Alcohol., January 1, 2005; 40(1): 2 - 14.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
B. S. BASAVARAJAPPA and B. L. HUNGUND
ROLE OF THE ENDOCANNABINOID SYSTEM IN THE DEVELOPMENT OF TOLERANCE TO ALCOHOL
Alcohol Alcohol., January 1, 2005; 40(1): 15 - 24.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
F. LALLEMAND and P. De WITTE
ETHANOL INDUCES HIGHER BEC IN CB1 CANNABINOID RECEPTOR KNOCKOUT MICE WHILE DECREASING ETHANOL PREFERENCE
Alcohol Alcohol., January 1, 2005; 40(1): 54 - 62.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. Racz, A. Bilkei-Gorzo, Z. E. Toth, K. Michel, M. Palkovits, and A. Zimmer
A Critical Role for the Cannabinoid CB1 Receptors in Alcohol Dependence and Stress-Stimulated Ethanol Drinking
J. Neurosci., March 15, 2003; 23(6): 2453 - 2458.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.